Pathologic classification of adenocarcinoma of lung

Journal of Surgical Oncology

Volumn 108, Issue 5, 2013, Pages 320-326

  Van Schil, Paul E ^a   Sihoe, Alan D L ^b   Travis, William D ^c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

adenocarcinoma; lung cancer; prognosis; staging; surgery; therapy; TNM classification

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER THERAPY; CARCINOMA IN SITU; COMPUTER ASSISTED TOMOGRAPHY; HIGH RISK POPULATION; HUMAN; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

ADENOCARCINOMA; LUNG CANCER; PROGNOSIS; STAGING; SURGERY; THERAPY; TNM CLASSIFICATION;

ADENOCARCINOMA; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884908529     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23397     Document Type: Review

References (42)

1. Travis WDBE, Müller-Hermelink HK, Harris CC:, World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus, and heart. Lyon: IARC Press; 2004.
2. Travis WD, Brambilla E, Noguchi M, et al.: International association for the study of lung cancer/American thoracic society/European respiratory society International multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-285.
3. Travis WD, Brambilla E, Van Schil P, et al.: Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification. Eur Respir J 2011; 38: 239-243.
4. Van Schil PE, Asamura H, Rusch VW, et al.: Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J 2012; 39: 478-486.
5. Kodama K, Higashiyama M, Yokouchi H, et al.: Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 2001; 33: 17-25.
6. Suzuki K, Asamura H, Kusumoto M, et al.: " Early" peripheral lung cancer: Prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002; 74: 1635-1639.
7. Takamochi K, Nagai K, Yoshida J, et al.: Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings. J Thorac Cardiovasc Surg 2001; 122: 325-330.
8. Sakurai H, Maeshima A, Watanabe S, et al.: Grade of stromal invasion in small adenocarcinoma of the lung: Histopathological minimal invasion and prognosis. Am J Surg Pathol 2004; 28: 198-206.
9. Adler B, Padley S, Miller RR, et al.: High-resolution CT of bronchioloalveolar carcinoma. AJR Am J Roentgenol 1992. 159: 275-277.
10. Aoki T, Tomoda Y, Watanabe H, et al.: Peripheral lung adenocarcinoma: Correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001; 220: 803-809.
11. Godoy MC, Naidich DP:, Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: Recommended interim guidelines for assessment and management. Radiology 2009; 253: 606-622.
12. Okada M, Nishio W, Sakamoto T, et al.: Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma. Ann Thorac Surg 2003; 76: 1828-1832. discussion 32.
13. Okada M, Tauchi S, Iwanaga K, et al.: Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. J Thorac Cardiovasc Surg 2007; 133: 1448-1454.
14. Suzuki K, Koike T, Asakawa T, et al.: A prospective study to evaluate radiological diagnostic criteria by thin-section computed tomography to predict pathological non-invasiveness in peripheral clinical IA lung cancer (JCOG 0201). J Thorac Oncol 2011; 6: 751-756.
15. Zhang L, Yankelevitz DF, Carter D, et al.: Internal growth of nonsolid lung nodules: Radiologic-pathologic correlation. Radiology 2012; 263: 279-286.
16. Kadota K, Colovos C, Suzuki K, et al.: FDG-PET SUVmax Combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma. Ann Surg Oncol 2012; 19: 3598-3605.
17. Chiu CH, Yeh YC, Lin KH, et al.: Histological subtypes of lung adenocarcinoma have differential (1)(8)F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan. J Thorac Oncol 2011; 6: 1697-1703.
18. Warth A, Stenzinger A, von Brunneck AC, et al.: Interobserver variability in the application of the novel iaslc/ats/ers classification. Eur Respir J 2012; 40: 1221-1227.
19. Thunnissen E, Beasley MB, Borczuk AC, et al.: Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An International interobserver study. Mod Pathol 2012.
20. Warth A, Cortis J, Fink L, et al.: Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification. Virchows Arch 2012; 461: 185-193.
21. Sigel CS, Moreira AL, Travis WD, et al.: Subtyping of non-small cell lung carcinoma: A comparison of small biopsy and cytology specimens. J Thorac Oncol 2011; 6: 1849-1856.
22. Sterlacci W, Savic S, Schmid T, et al.: Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact. Am J Clin Pathol 2012; 137: 946-956.
23. Yoshizawa A, Motoi N, Riely GJ, et al.: Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011; 24: 653-664.
24. Goldstraw P, Crowley J, Chansky K, et al.: The IASLC lung cancer staging project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2: 706-714.
25. Solis LM, Behrens C, Raso MG, et al.: Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer 2012; 118: 2889-2899.
26. Kadara H, Behrens C, Yuan P, et al.: A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis. Clin Cancer Res 2011; 17: 1490-1501.
27. Russell PA, Wainer Z, Wright GM, et al.: Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International association for the study of lung cancer/American thoracic society/European respiratory society International multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 2011; 6: 1496-1504.
28. Warth A, Muley T, Meister M, et al.: The novel histologic International association for the study of lung cancer/American thoracic society/European respiratory society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012; 30: 1438-1446.
29. Franklin WA, Aisner DL, Varella-Garcia M:, Prognostic patterns in the histopathology of pulmonary adenocarcinoma. J Clin Oncol 2012; 30: 1401-1403.
30. van Klaveren RJ, Oudkerk M, Prokop M, et al.: Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361: 2221-2229.
31. El-Sherif A, Gooding WE, Santos R, et al.: Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis. Ann Thorac Surg 2006; 82: 408-415.
32. Nakamura H, Kawasaki N, Taguchi M, et al.: Survival following lobectomy vs limited resection for stage I lung cancer: A meta-analysis. Br J Cancer 2005; 92: 1033-1037.
33. Okada M, Koike T, Higashiyama M, et al.: Radical sublobar resection for small-sized non-small cell lung cancer: A multicenter study. J Thorac Cardiovasc Surg 2006; 132: 769-775.
34. Yoshida J, Ishii G, Yokose T, et al.: Possible delayed cut-end recurrence after limited resection for ground-glass opacity adenocarcinoma, intraoperatively diagnosed as Noguchi type B, in three patients. J Thorac Oncol 2010; 5: 546-550.
35. Rami-Porta R, Tsuboi M:, Sublobar resection for lung cancer. Eur Respir J 2009; 33: 426-435.
36. Blasberg JD, Pass HI, Donington JS:, Sublobar resection: A movement from the lung cancer study group. J Thorac Oncol 2010; 5: 1583-1593.
37. Fan J, Wang L, Jiang GN, et al.: Sublobectomy versus lobectomy for stage I non-small-cell lung cancer. A meta-analysis of published studies. Ann Surg Oncol 2012; 19: 661-668.
38. Kodama K, Higashiyama M, Takami K, et al.: Treatment strategy for patients with small peripheral lung lesion(s): Intermediate-term results of prospective study. Eur J Cardiothorac Surg 2008; 34: 1068-1074.
39. Tsutani Y, Miyata Y, Nakayama H, et al.: Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. J Thorac Cardiovasc Surg 2012; 144: 1365-1371.
40. Hattori A, Suzuki K, Matsunaga T, et al.: Is limited resection appropriate for radiologically "solid" tumors in small lung cancers ? Ann Thorac Surg 2012; 94: 212-215.
41. Veronesi G, Maisonneuve P, Pelosi G, et al.: Screening-detected lung cancers: Is systematic nodal dissection always essential ? J Thorac Oncol 2011; 6: 525-530.
42. Tsutani Y, Miyata Y, Nakayama H, et al.: Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study. J Thorac Cardiovasc Surg 2012; 143: 607-612.